BioVie, Inc. (BIVI)
1.69
+0.03
(+1.81%)
USD |
NASDAQ |
May 07, 09:44
BioVie Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lantern Pharma, Inc. | -1.704M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Savara, Inc. | -93.56M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.438M |
| Free Cash Flow | -14.32M |
| Free Cash Flow Per Share (Quarterly) | -0.5603 |
| Free Cash Flow to Equity (Quarterly) | -4.420M |
| Free Cash Flow to Firm (Quarterly) | -4.432M |
| Free Cash Flow Yield | -101.0% |